It has been argued that the existing epidemiologic data are insufficient to establish a causal link between acute kidney injury (AKI) and subsequent development or progression of chronic kidney disease (CKD), especially given that risk factors for the development of AKI overlap with those for progressive CKD.
INTRODUCTION
]. It is well recognized that AKI is associated with significant short-term morbidity and mortality, with hospital mortality rates exceeding 50% when severe AKI complicates critical illness [3 & ]. The effect of AKI on longer-term outcomes has been less well elucidated, but has received increasing attention over the course of the past decade. In addition, the use of consensus definitions for AKI that have standardized categorization of less severe decrements in kidney function has facilitated the analysis of milder degrees of AKI on long-term kidney function [4, 5, 6 && ]. These analyses have challenged the classic teaching that the majority of patients who survive an episode of AKI have near complete recovery of kidney function and an excellent long-term prognosis [7] and have demonstrated a strong association between episodes of AKI and subsequent development, and progression, of chronic kidney disease (CKD) [8 && ,9 && ]. It has been argued, however, that the existing epidemiologic data are insufficient to establish causality, especially given that risk factors for the development of AKI overlap with those for progressive CKD [10 && ]. In this review, we summarize both the epidemiologic and experimental data relating AKI to CKD and assess the strength of the data supporting a causal association.
CASE SERIES DESCRIBING THE OUTCOME OF SEVERE ACUTE KIDNEY INJURY
Case series dating back to the 1950s have described residual functional abnormalities among patients surviving episodes of dialysis-requiring AKI. For example, in a study published in 1952, Lowe et al. [11] evaluated 14 patients who survived episodes of acute tubular necrosis (ATN) and reported that three out of eight patients had a creatinine clearance of less than 80 ml/min despite the absence of evidence of baseline renal impairment, and attributed the renal dysfunction to 'scarring or vascular damage'. Similarly, in 1956, Finkenstaedt and Merrill [12] provided follow-up on 16 patients who survived severe AKI at 13-76 months. Six of the 16 patients were found to have inulin clearances of less than 70 ml/min, despite having no evidence of prior renal dysfunction, concluding that the AKI 'resulted in more chronic renal damage than would be expected,' and speculating that the chronic dysfunction resulted from nephron loss, basement membrane rupture, and abnormal epithelial regeneration. Subsequent studies demonstrated residual defects in tubular function, including acidification defects, tubular wasting of electrolytes, and renal concentrating defects [13, 14] . On the basis of these early studies, classic textbook teaching had been that the majority of patients surviving an episode of severe AKI resulting from ATN had a good prognosis, with statements such as '. . .the vast majority of patients who survive an episode of ATN achieve clinically normal function and maintain it indefinitely, despite the persistence of subtle functional defects in many' [15] .
Several case series have highlighted a high mortality rate in patients surviving an episode of AKI and have suggested an increased risk for progressive kidney disease. Liaño et al. [16] followed a cohort of 187 consecutive patients from Madrid, Spain for up to 22 years (median 7.2 years) after surviving an episode of severe AKI attributable to ATN. Ninety-five patients (51%) died during followup with Kaplan-Meir estimates of survival of 50% at 10 years and 40% at 15 years. Fifty-seven of the surviving patients (62%) had their kidney function assessed; the vast majority were characterized as having normal kidney function, although 15.8% had mild and 3.5% had moderate impairment of kidney function and three patients (1.7%) had developed a need for chronic dialysis, at 6, 11 and 12 years of follow-up. Schiffl and Fischer [17] provided long-term follow-up of a cohort of 425 critically ill patients with severe AKI secondary to ATN from a single center. The overall in-hospital mortality was 47%; among survivors, recovery of kidney function at hospital discharge was complete [defined as glomerular filtration rate (GFR) within 10% of baseline] in 57%, and partial in 43%. None of the surviving patients needed dialysis at the time of discharge. After 5 years of follow-up, only 25% of the initial cohort remained alive. Of the surviving patients, 86% had normal kidney function, 5% had developed end-stage renal disease (ESRD) and 9% had impaired kidney function.
EPIDEMIOLOGICAL ASSOCIATIONS BETWEEN ACUTE KIDNEY INJURY AND DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN ADULTS
A series of epidemiologic studies published since 2009 have demonstrated a strong association between AKI and CKD. Using administrative data from a 5% sample of Medicare beneficiaries and linking to data from the United States Renal Data System, Ishani et al. [18] observed a hazard of developing ESRD over 2 years of follow-up as approximately 6.5 times greater [95% confidence interval (CI): 5.9-7.7] in patients who had a discharge diagnosis of AKI compared to patients without AKI. When stratified, based on the presence of underlying CKD, the hazard for developing ESRD was 13 times higher (95% CI: 10.6-16.0) in patients with de-novo AKI, and approximately 41 times higher (95% CI: 34.6-49.1) in patients with acute-on-CKD compared to matched patients surviving acute illness with no diagnoses of acute or CKD. In contrast, the 2-year hazard of developing ESRD in patients with CKD but no AKI was 8.4 times (95% CI: 7.4-9.6) that of patients with no underlying kidney disease [18] .
In a retrospective study, using data from the Kaiser Permanente of Northern California Health System on 343 patients who survived an episode of dialysis-requiring AKI and remained dialysis independent for at least 30 days after hospital discharge and 3430 matched patients without AKI, Lo et al. [19] reported a 28-fold increased risk of developing advanced CKD (95% CI: 21.1-37.6) following an episode of AKI The hazard was even higher in patients with baseline preserved kidney function 
KEY POINTS
There is a strong epidemiologic association between development of AKI and subsequent development and progression of CKD.
The epidemiologic association is seen across a broad array of clinical settings, with a graded risk of development of CKD with increased severity or increased number of episodes of AKI.
The link between AKI and subsequent CKD is supported by experimental data demonstrating vascular rarefaction and activation of fibrotic pathways following AKI.
Common risk factors for the development of both AKI and CKD make it difficult to definitively establish a causal relationship on the basis of epidemiologic data.
The preponderance of evidence supports the causal link between AKI and subsequent CKD.
developed progressive CKD, defined as an estimated GFR less than 30 ml/min/1.73 m 2 , and 41 patients progressed to ESRD, giving an event rate for progressive CKD of 47.9 per 100-person-years for AKI patients compared with 1.7 per 100-person-years for non-AKI patients.
Using provincial health registry data from Ontario, Canada, Wald et al. [20] observed an incidence rate for ESRD of 2.63 cases per 100-personyears over 10 years of follow-up in patients surviving an episode of dialysis-requiring AKI and who remained dialysis-independent 30 days after hospital discharge compared to 0.91 cases per 100-personyears in a matched cohort of patients who did not have AKI (HR: 3.2; 95% CI: 2.7-3.9). In a subsequent analysis of patients who had nondialysis-requiring AKI, the corresponding incidence rates for ESRD were 1.8 and 0.7 cases per 100 person-years (HR: 2.7; 95% CI: 2.4-3.0) [21 & ].
Amdur et al. [22] assessed long-term kidney function in patients with no prior history of CKD who were hospitalized with AKI, using an electronic database from the United States Department of Veterans Affairs (VA) health system and comparing outcomes to patients without evidence of kidney disease who were hospitalized for acute myocardial infarction or pneumonia. They also found that AKI was associated with an increased risk for the development of advanced CKD and reduced survival compared to controls. In a subsequent analysis, the authors reported that severity of AKI was a robust predictor of risk for the development and progression of CKD [23] . Other predictors of progression in this cohort that excluded patients with underlying CKD were advanced age, low serum albumin levels, and a diagnosis of diabetes mellitus.
In ] published a systematic review and meta-analysis of the epidemiologic studies that addressed the risk of CKD after AKI. They reported a pooled incidence of CKD in the 13 included studies of 25.5 cases per 100-personyears (range 3.4-72.2) an adjusted HR for the development of CKD of 8.8 (95% CI: 3.0-25.5). Similarly, the pooled incidence of ESRD was 8.6 cases per 100-person-years (range 0.6-28.1) giving an adjusted HR of 3.1 (95% CI: 1.9-5.0).
In a subsequent study that was not included in this meta-analysis, Bucaloiu et al. [24 && ] interrogated the electronic medical records from the Geisinger Health System in Pennsylvania to examine the risks for death and de-novo CKD in patients with no history of kidney disease who developed AKI with subsequent complete recovery of kidney function (defined as an estimated GFR of at least 90% of baseline) within 90 days. They observed a hazard for the development of de-novo CKD over a follow-up period of up to 6 years of 1.9 (95% CI: 1.8-2.1) compared to patients with no history of either AKI or CKD, with a hazard for death of 1.5 (95% CI: 1.2-1.8). Of note, however, was a significant interaction between the risk for development of CKD and mortality risk; after adjusting for development of CKD, the hazard for death was attenuated and was no longer statistically significant.
Two subsequent analyses have also demonstrated associations between severity or recurrent episodes of AKI and subsequent CKD. Using the Department of Veterans Affairs National Surgical Quality Improvement Program Database, Ishani et al. [25] observed a progressive risk for the development of CKD with graded severity of postcardiac surgery AKI, using definitions based on maximal increases in serum creatinine ranging from less than 25% (no AKI) to more than 100%. In another study utilizing VA data, Thakar et al. [26] observed a relationship between the number of episodes of AKI and subsequent development of stage 4 CKD in a cohort of 3679 patients with diabetes mellitus at a single VA Medical Center. The hazard for development of stage 4 CKD in patients with AKI was 3.6 (95% CI: 2.8-4.6) compared to patients with no AKI, and doubled with each episode of AKI (HR 2.0; 95% CI: 1.8-2.3).
Although all these studies demonstrate a similar strong association between AKI and subsequent CKD, they are unable to establish an etiologic association. In addition to underlying CKD being a risk factor for AKI, underlying hypertension, diabetes, and cardiovascular disease are implicated as risk factors for both AKI and CKD. Although adjustment for these factors in multivariable statistical models can attempt to adjust for this, residual confounding cannot be ruled out. Thus, it remains possible that rather than being a mediator for the development of CKD, episodes of AKI are merely markers of risk, reflecting the severity of other underlying etiologic factors.
ASSOCIATIONS BETWEEN ACUTE KIDNEY INJURY AND DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN CHILDREN
Unlike the large proportion of adults who develop AKI superimposed on a substrate of hypertension, diabetes mellitus, chronic vascular disease, and underlying CKD, these factors generally do not underlie the development of AKI in children. [2 & ]. Thus, the subsequent development of CKD in children surviving an episode of AKI is more readily attributable to residual kidney injury from the AKI. Askenazi et al. [27] reported on the longitudinal follow-up of 174 children from a single tertiary care center with AKI between 1998 and 2001 who survived to hospital discharge. The majority of these children had complete recovery of kidney function, although 24 (14%) had incomplete recovery of kidney function and 11 (5%) were dialysis-dependent at hospital discharge [28] . During the subsequent follow-up, 35 children (21.1%) died and 16 (9.2%) progressed to ESRD. Twenty-nine surviving children without ESRD underwent formal renal functional testing. Seventeen of the 29 (58.6%) children had evidence of chronic kidney injury, six were hypertensive, eight had albuminuria, nine had hyperfiltration (creatinine clearance > 150 ml/min/1.73 m 2 ), and four had reduced GFR (creatinine clearance < 90 ml/min/1.73 m 2 ). Although these findings must be interpreted with caution as only a minority of the surviving children were evaluated, and there was overrepresentation of children with underlying renal and urologic disease, these studies do suggest a significant burden of CKD on pediatric survivors of AKI.
Follow-up of children who developed enterotoxigenic hemolytic uremic syndrome (HUS) as the result of contamination of a municipal water supply with E. coli O157:H7 also provides insight into the effect of AKI on subsequent kidney function [29] . Of 28 children who developed HUS, one child had preexistent proteinuria, and one child died. Nineteen of the remaining 26 children underwent follow-up evaluation for 5 years after the outbreak. Three of 15 (20%) of the children who had HUS had elevated urine albumin excretion compared to two of 60 (3%) of unaffected children (relative risk: 6.0; 95% CI: 1.1-32.8). Although there was no difference in serum creatinine levels, the children who had HUS had higher serum cystatin C concentrations (0.93 AE 0.1 vs. 0.86 AE 0.1, P ¼ 0.01) and lower cystatin C-based estimated GFRs (100 AE 12.2 vs. 110 AE 15.5, P ¼ 0.02) compared to unaffected controls. Thus, in this cohort of children with no prior history of kidney disease, AKI due to HUS is associated with residual kidney damage; however, these findings may not be generalizable to other causes of AKI.
ANIMAL DATA SUPPORTING AN ETIOLOGICAL ASSOCIATION BETWEEN ACUTE KIDNEY INJURY AND CHRONIC KIDNEY DISEASE
Data from experimental models of AKI provide insight into biological mechanisms by which AKI contributes to subsequent CKD and support an etiologic relationship [9 && ,30]. A detailed discussion of these data is beyond the scope of this review. One of the implicated mechanisms is vascular rarefaction, as demonstrated by studies which showed a 30-50% reduction in peritubular capillary density in the inner stripe of the outer medulla following ischemia reperfusion injury [31] . This loss of vascularity is hypothesized to lead to tubulointerstitial hypoxia, tubular atrophy, and interstitial fibrosis. It has been shown that recovery from AKI is characterized by proliferation of tubular epithelial cells [32] . However, with severe AKI there is an increase in the number of proximal tubule epithelial cells arrested in the G2/M phase of the cell cycle [32, 33] . Cell cycle arrest is associated with increased production of profibrotic cytokines including transforming growth factor b-1 and connective tissue growth factor [32, 33] .
CONCLUSION
Despite the strong epidemiologic association between AKI and subsequent development or progression of CKD, these studies alone cannot establish causality [10 && ]. Many of the risk factors for AKI are also independent risk factors for the development or progression of CKD (Fig. 1) . Although statistical models can be used to adjust for these common risks, there is significant potential for residual confounding. However, the preponderance of evidence supports the presence of a causal link between AKI and CKD [34 && ]. Nine criteria have generally been accepted as necessary for the inference of causality in observational associations [35] :
(1) Strength of association (2) Consistency (3) Specificity (4) Temporality (5) Biological gradient (6) Plausibility (7) Coherence (8) Experiment (9) Analogy
To some extent, all nine of these are fulfilled in evaluating AKI as a cause for CKD. In laying out these criteria in his address to the Royal Society of Medicine, Sir Austin Bradford Hill cautioned that none of these criteria '. . .can bring indisputable evidence for or against the cause-and-effect hypothesis and none can be required as a sine qua non' [35] .
It is certainly true that many patients who sustain an episode of AKI do not subsequently develop CKD and that the risk of subsequent CKD may vary with both cause and severity of an acute injury.
Although a randomized trial of the induction of AKI would provide definitive proof of the presence or absence of a causal relationship for subsequent CKD in surviving patients, such a study would be patently unethical. However, the demonstration that an intervention that significantly mitigates the risk for AKI also diminishes the risk for subsequent CKD would be strong, albeit less definitive, evidence for causation. Although more rigorous studies of the long-term sequelae of AKI are needed, and several are underway, the preponderance of data currently support the existence of a causal pathway between episodes of AKI and subsequent development, or progression, of CKD. Emphasis should therefore be placed on the prevention of AKI, not only to mitigate short-term morbidity and mortality, but also to diminish the long-term consequences on kidney function.
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